Researchers from Kaiser Permanente Publish Research in Antineoplastics (Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma)

Source :: Health & Medicine Week. May 7, 2021, 6358
Publication Year :: 2021
Abstract: 2021 MAY 7 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in antineoplastics. According to news originating from the Kaiser [...]

Subjects :: Gemcitabine -- Research
Health maintenance organizations -- Research -- Comparative analysis
Sarcoma -- Research -- Care and treatment
Docetaxel -- Research
Chemotherapy -- Research -- Comparative analysis
Cancer -- Chemotherapy
Health
Kaiser Permanente

Tools